Live Earnings Conference Call: Standard BioTools will host a live Q1 2025 earnings call on May 6, 2025 at 4:30PM ET. Follow this link to get details and listen to Standard BioTools' Q1 2025 earnings call when it goes live. Get details. Standard BioTools (LAB) News Today $1.15 -0.05 (-4.17%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$1.14 0.00 (-0.43%) As of 05/5/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Standard BioTools Q1 2025 Earnings PreviewMay 5 at 7:47 PM | msn.comStandard BioTools (LAB) Expected to Announce Earnings on TuesdayStandard BioTools (NASDAQ:LAB) will be releasing its Q1 2025 earnings after the market closes on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-standard-biotools-inc-stock/)May 1, 2025 | marketbeat.comStandard BioTools announces new product innovations at AACR 2025April 24, 2025 | markets.businessinsider.comStandard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025April 24, 2025 | globenewswire.comStandard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025April 22, 2025 | globenewswire.comMirabella Financial Services LLP Makes New Investment in Standard BioTools Inc. (NASDAQ:LAB)Mirabella Financial Services LLP acquired a new stake in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 3,130,190 shares of the company's stock, valued at approximately $5,478,000. MirabellaApril 22, 2025 | marketbeat.comRoyce & Associates LP Purchases 840,951 Shares of Standard BioTools Inc. (NASDAQ:LAB)Royce & Associates LP boosted its position in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 136.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,455,503 shares of the company's stock after purchaMarch 22, 2025 | marketbeat.comPrimecap Management Co. CA Reduces Holdings in Standard BioTools Inc. (NASDAQ:LAB)Primecap Management Co. CA lessened its holdings in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 78.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 641,974 shares of the company's stock aMarch 21, 2025 | marketbeat.comNikko Asset Management Americas Inc. Lowers Stake in Standard BioTools Inc. (NASDAQ:LAB)Nikko Asset Management Americas Inc. lessened its position in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 30.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,618,394 shares of the cMarch 18, 2025 | marketbeat.comInsider Buying: Standard BioTools Inc. (NASDAQ:LAB) Director Purchases 4,820,959 Shares of StockStandard BioTools Inc. (NASDAQ:LAB - Get Free Report) Director Casdin Partners Master Fund, L bought 4,820,959 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were acquired at an average cost of $1.06 per share, for a total transaction of $5,110,216.54. Following the completion of the purchase, the director now owns 58,846,780 shares in the company, valued at $62,377,586.80. This trade represents a 8.92 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.March 5, 2025 | marketbeat.comCasdin Partners Master Fund, L Buys 4,820,959 Shares of Standard BioTools Inc. (NASDAQ:LAB) StockMarch 5, 2025 | insidertrades.comQ1 Earnings Forecast for Standard BioTools Issued By KeyCorpStandard BioTools Inc. (NASDAQ:LAB - Free Report) - Investment analysts at KeyCorp issued their Q1 2025 earnings estimates for Standard BioTools in a research report issued to clients and investors on Wednesday, February 26th. KeyCorp analyst P. Knight forecasts that the company will earn ($0.06)March 3, 2025 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Analysts Are Cutting Their Estimates: Here's What You Need To KnowMarch 1, 2025 | uk.finance.yahoo.comQ4 2024 Standard BioTools Inc Earnings CallFebruary 27, 2025 | uk.finance.yahoo.comStandard BioTools downgraded to Sector Weight from Overweight at KeyBancFebruary 27, 2025 | markets.businessinsider.comStandard BioTools Inc. (NASDAQ:LAB) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | msn.comKeybanc Downgrades Standard BioTools (LAB)February 27, 2025 | msn.comStandard BioTools (NASDAQ:LAB) Announces Earnings ResultsStandard BioTools (NASDAQ:LAB - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.07) EPS for the quarter, meeting analysts' consensus estimates of ($0.07). Standard BioTools had a negative return on equity of 27.05% and a negative net margin of 79.92%.February 27, 2025 | marketbeat.comStandard BioTools Inc. Faces Revenue Decline Amid Market ChallengesFebruary 27, 2025 | tipranks.comStandard BioTools to Participate in Upcoming Investor ConferencesFebruary 27, 2025 | globenewswire.comShareholders in Standard BioTools (NASDAQ:LAB) have lost 66%, as stock drops 10.0% this past weekFebruary 27, 2025 | uk.finance.yahoo.comStandard BioTools reports Q4 EPS (9c), consensus (3c)February 27, 2025 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Standard BioTools (LAB) and Ardent Health Partners, Inc. (ARDT)February 27, 2025 | markets.businessinsider.comStandard BioTools Inc. (LAB) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comStandard BioTools Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 26, 2025 | globenewswire.comARK Investment Management LLC Cuts Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB)ARK Investment Management LLC decreased its position in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 62.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,323,689 shares of the company's stock after selling 5,6February 26, 2025 | marketbeat.comStandard BioTools Inc (LAB) Q4 2024 Earnings Report Preview: What To Look ForFebruary 26, 2025 | finance.yahoo.comStandard BioTools (LAB) Expected to Announce Earnings on WednesdayStandard BioTools (NASDAQ:LAB) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=497828)February 19, 2025 | marketbeat.comStandard BioTools (NASDAQ:LAB) Trading 7.1% Higher - Should You Buy?Standard BioTools (NASDAQ:LAB) Trading 7.1% Higher - Should You Buy?February 15, 2025 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Shares Sold by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. lowered its stake in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 30.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,618,394 shares of the company's stock afteFebruary 13, 2025 | marketbeat.comStandard BioTools (NASDAQ:LAB) Reaches New 12-Month Low - Here's WhyStandard BioTools (NASDAQ:LAB) Sets New 52-Week Low - Here's WhyFebruary 12, 2025 | marketbeat.comStandard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025February 12, 2025 | globenewswire.comStandard BioTools (NASDAQ:LAB) Trading Down 5.8% - What's Next?Standard BioTools (NASDAQ:LAB) Shares Down 5.8% - Time to Sell?January 29, 2025 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Down 8.5% - Here's WhyStandard BioTools (NASDAQ:LAB) Shares Down 8.5% - Time to Sell?January 23, 2025 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Gap Down - Time to Sell?Standard BioTools (NASDAQ:LAB) Shares Gap Down - Here's WhyJanuary 22, 2025 | marketbeat.comUS bans on China exports hit lab instrument makersJanuary 16, 2025 | msn.comStandard BioTools stock soars on upbeat preliminary 4Q revenueJanuary 14, 2025 | investing.comStandard BioTools (NASDAQ:LAB) Trading Down 5.8% - Here's What HappenedStandard BioTools (NASDAQ:LAB) Trading Down 5.8% - Should You Sell?January 14, 2025 | marketbeat.comStandard BioTools reports preliminary Q4 revenue $46.5M, consensus $43.03MJanuary 14, 2025 | markets.businessinsider.comStandard BioTools stock soars on Q4 revenue beatJanuary 13, 2025 | in.investing.comStandard BioTools (NASDAQ:LAB) Shares Gap Up - What's Next?Standard BioTools (NASDAQ:LAB) Shares Gap Up - Time to Buy?January 13, 2025 | marketbeat.comStandard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 RevenueJanuary 13, 2025 | globenewswire.comStandard BioTools Announces CCO Jeremy Davis’s DepartureJanuary 10, 2025 | markets.businessinsider.comIn the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap drop, institutional owners may be forced to take severe actionsJanuary 2, 2025 | finance.yahoo.comStandard BioTools (NASDAQ:LAB) Stock Price Down 6.3% - What's Next?Standard BioTools (NASDAQ:LAB) Shares Down 6.3% - Time to Sell?December 27, 2024 | marketbeat.comState Street Corp Purchases 1,157,984 Shares of Standard BioTools Inc. (NASDAQ:LAB)State Street Corp grew its stake in shares of Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 26.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,495,136 shares of the company's stock afteDecember 27, 2024 | marketbeat.comStandard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Barclays PLCBarclays PLC raised its position in Standard BioTools Inc. (NASDAQ:LAB - Free Report) by 13.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 3,228,360 shares of the company's stock after buying an additional 377,195 shares during the quarter. Barclays PLCDecember 20, 2024 | marketbeat.comStandard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 19, 2024 | globenewswire.comStandard BioTools (NASDAQ:LAB) Trading Down 6.8% - Here's What HappenedStandard BioTools (NASDAQ:LAB) Trading Down 6.8% - Here's What HappenedDecember 18, 2024 | marketbeat.comStandard BioTools (NASDAQ:LAB) Shares Up 9.9% - Still a Buy?Standard BioTools (NASDAQ:LAB) Shares Up 9.9% - Should You Buy?December 16, 2024 | marketbeat.com Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address LAB Media Mentions By Week LAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LAB News Sentiment▼0.000.72▲Average Medical News Sentiment LAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LAB Articles This Week▼22▲LAB Articles Average Week Get Standard BioTools News Delivered to You Automatically Sign up to receive the latest news and ratings for LAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 10x Genomics News Transcat News Cytek Biosciences News Senseonics News EyePoint Pharmaceuticals News Allient News Aehr Test Systems News Quanterix News Quantum-Si News 908 Devices News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LAB) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Standard BioTools With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LAB Stock Free LAB Stock Alerts